The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Registered INHAM adviser to major U.S. timber producer
Represented registered corporate "INHAM" adviser to a major U.S. forest products manufacturer. Ongoing representation of INHAM more
Business combination of Certegy Inc. and Fidelity National Information Services Inc.
Represented Certegy Inc., a major publicly held credit card and check verification company, in its $4.5 billion merger with Fidelity National more
Domain name dispute actions for multiple representative clients
The firm represented numerous trademark owners in domain name dispute actions arising under the Anti-Cybersquatting Consumer Protection Act and under more
Headquarters relocation for Optimal Technologies Inc., a green technology company
Represented Optimal Technologies Inc., a technology company specializing in energy distribution network analysis and optimization technologies, in more